Saleeby, E., Bielinski, K., Fitzgerald, A., Siegel, J. and Ibrahim, S. (2022) “A Prospective, Multi-Center Clinical Utility Study Demonstrates That the 40-Gene Expression Profile (40-GEP) Test Impacts Clinical Management for Medicare-Eligible Patients with High-Risk Cutaneous Squamous Cell Carcinoma (cSCC)”, SKIN The Journal of Cutaneous Medicine, 6(6), pp. 482–496. doi: 10.25251/skin.6.6.5.